My mind sometimes works in strange and mysterious ways. I was reading Fierce Biotech this morning and saw that Chris Viehbacher indicated that Sanofi will spend up to $2.6 B on acquisitions next year -- at least that is the budget for a more limited "string of pearls" strategy.
But I had to smile when he was quoted in the article as saying, "The trick in M&A is to go find something not everybody is looking at."
I will now dub this, in homage to Wee Willie Keeler, the "Buy 'em where they ain't" strategy.
Posted by Bruce Lehr Jan 12th 2012.
Viehbacher comments on innovation and the changing face of R&D in Xconomy interview (Jan 17th).
http://www.xconomy.com/national/2012/01/17/sanofi-ceo-chris-viehbacher-on-stirring-innovation-in-the-era-of-rd-cutbacks/
Posted by: bigredbruce | 01/18/2012 at 12:17 PM
More comments from Viehbacher on R&D spending on internal and external projects as reported in Fierce Biotech (Jan 18th)
http://www.fiercebiotech.com/story/viehbacher-repositioning-sanofi-fast-changing-rd-ecosystem/2012-01-17?utm_medium=rss&utm_source=rss
Posted by: bigredbruce | 01/18/2012 at 12:15 PM